News
Medical-device maker Edwards Lifesciences shares ticked up after rival Boston Scientific said it would stop selling its rival heart-valve replacement systems. The systems, called transcatheter aortic ...
Engineering Explained on MSN1h
How VTEC Works (In 60 Seconds)VTEC is Honda's variable valve technology used to change the amount of valve lift and valve duration in the engine. By altering valve lift and duration, you can influence how much air the engine ...
The company, with a huge Minnesota cardiology division, is axing its Acurate devices, citing conversations with regulators.
A deep dive into the technological progress of today’s smart valves, bearings, brakes, gearboxes and actuators, and what’s next.
Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
Explore more
The neuroscience startup owned by Valve cofounder Gabe Newell is set to unveil its first brain chip this year.
Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...
Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...
A large elephant seal took a wrong turn and was seen lumbering along a street in a coastal town in South Africa early Tuesday ...
Boston Scientific has discontinued global sales of its Acurate neo2 and Acurate Prime transcatheter aortic valve replacement (TAVR) systems.
Boston Scientific said it still expects to achieve its second-quarter and full-year 2025 sales and adjusted per-share earnings guidance despite the anticipated financial impacts from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results